Product Images Enoxaparin Sodium

This appears to be a table showing the relative risk of several subgroups based on factors such as sex, age, infarct location, and prior MI (myocardial infarction). The table shows the number of patients in each subgroup, the use of UFH or Enox, and the reduction in risk percentage.*

The text describes the results of a Log-Rank Test with a p value of less than 0.0001. There are some illegible characters resulting from . There are two groups identified, one treated with Enoxaparin and another treated with UFH. A plot shows a time range of days and the number of participants at different time points. The plot shows the time to death or myocardial infarction over a period of one year.*

Enoxaparin Sodium Injection is a medication available in single-dose syringe form for subcutaneous injection derived from porcine. Each syringe contains 30mg Enoxaparin Sodium Injection. This medication is used for blood clot prevention and should be used as per the instructions provided in the package insert. It is important to keep out of reach of children, and store the medication at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The syringes are equipped with an automatic safety device for subcutaneous injection. This medication is manufactured by Sanofi, with the direction for use available for the single-dose syringe with an automatic safety device.*

This is a description of a medication called Enoxaparin Sodium Injection sold in single-dose syringes with automatic safety devices. The medication is for subcutaneous injection only, and the dosages are contained in each syringe. The package insert should be used to find the appropriate dosage and administration techniques. The text includes dosage and storage warnings and manufacturer information.*

Enoxaparin Sodium Injection is a medication derived from porcine intestinal mucosa and packaged as 60mg syringes for subcutaneous injection. Each 0.025mL graduation contains 2.5mg of Enoxaparin Sodium Injection. It comes with a package insert that includes dosage information, administration guidelines, and warnings to keep it out of reach of children. The syringe is equipped with an automatic safety device that covers the needle after injection. However, the user is advised not to replace the needle shield after injection. The text also includes NDC codes and a Datamatrix code for serialization.*

Enoxaparin Sodium is an injectable medication provided in 10 single-dose syringes with automatic safety devices for subcutaneous injection. The syringe must be emptied before activating the safety system, and the needle shield should be removed before injection. The protective sleeve will automatically cover the needle and shield an audible "click" will be heard to confirm its activation. Each syringe contains 80mg Enoxaparin Sodium Injection. The medication is for subcutaneous injection, and each 0.025mL graduation equals 2.5mg Enoxaparin Sodium Injection. A warning is given to keep the medication out of reach of children and store at 25°C (77°F). The syringe box has a NDC of 0955-1008-10.*

This is a description of L Enoxaparin Sodium Injection, a medication that comes in a single dose syringe containing 100mg Enoxaparin Sodium Injection derived from porcine intestinal mucosa in Water for Injection. It is administered via subcutaneous injection. Each 0.025mL reduction equals 2.5mg Enoxaparin Sodium Injection. Dosage information and directions for use are available in the package insert. The medication should be kept out of reach of children. The NDC code is 0955-1010-10. The syringe contains an automatic safety device. Directions for use of the syringe with the safety device are included. The product is manufactured by Winthrop, a Sanofi company. The lot and expiration dates are on a Datamatrix code.*

Enoxaparin Sodium Injection is a medication used for subcutaneous or intravenous administration to prevent or treat blood clots. Each 0.1mL of Enoxaparin Sodium comprises 10mg enoxaparin sodium derived from porcine intestinal mucosa in Water for Injection, and 1.5 mg benzyl alcohol. The recommended dosage and administration can be found in the package insert. Multiple dose vials should not be used beyond 28 days after the first use. It should be stored at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. SANOFI Company produces the medication in a 3 mL multiple dose vial.*

This is a description of Enoxaparin Sodium Injection, a medication that is subcutaneously injected for the prevention of blood clots. The syringes are single-dose and come with an automatic safety device. The syringes come in a pack of 10, and each syringe contains 120 mg of the medication. The medication is derived from porcine intestinal mucosa in water for injection, and each 0.02mL graduation equals 3mg Enoxaparin Sodium Injection. The package insert contains information on dosage and administration. The medication must be kept out of reach of children and stored at 25°C (77°F), with excursions permitted to 15-30°C (59-86°F). The medication is manufactured and distributed by Winthrop U.S., a business of Sanofi-Aventis U.S. LLC. The text provides instructions on how to use the single-dose syringe with automatic safety device, which should be disposed of immediately after use in a sharps container.*

Enoxaparin Sodium Injection is a medication that comes in a single-dose syringe with an automatic safety device for subcutaneous injection. Each syringe has 150mg of Enoxaparin Sodium derived from porcine intestinal mucosa in water for injection. The dosage and administration instructions can be found on the package insert, with each 0.02mL graduation equaling 3mg. The medication must be kept out of reach of children and stored at 25 degrees Celcius, with excursions permitted to 15-30 degrees Celsius. The manufacturer is Winthrop U.S., a business of Sanofi-Aventis, LLC. The NDC number is 0955-1015-10. The document contains additional information on how to use the syringe and activate the safety system.*